TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹156 Cr | ₹157 Cr | ₹151 Cr | ₹129 Cr | ₹123 Cr |
What is the latest Contingent Liabilities ratio of TORRENT PHARMACEUTICALS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹156 Cr |
| Mar2024 | ₹157 Cr |
| Mar2023 | ₹151 Cr |
| Mar2022 | ₹129 Cr |
| Mar2021 | ₹123 Cr |
How is Contingent Liabilities of TORRENT PHARMACEUTICALS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹156 Cr | -0.84 | |
| Mar2024 | ₹157 Cr | 4.38 | |
| Mar2023 | ₹151 Cr | 17.16 | |
| Mar2022 | ₹129 Cr | 4.76 | |
| Mar2021 | ₹123 Cr | - | |
Compare Contingent Liabilities of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹148,220.9 Cr | 0.5% | 7% | 37.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹442,893.0 Cr | -0.2% | 7.5% | 5.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,367.0 Cr | -0.9% | 11.5% | 9.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,010.0 Cr | -3.1% | 4.8% | 10.3% | Stock Analytics | |
| CIPLA | ₹104,366.0 Cr | -5.4% | 5.5% | -13.5% | Stock Analytics | |
| MANKIND PHARMA | ₹98,147.9 Cr | 0.7% | 15.7% | 1.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | 0.5% |
7% |
37.4% |
| SENSEX | -3.2% |
-3.9% |
-7.5% |
You may also like the below Video Courses